These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

735 related articles for article (PubMed ID: 12447671)

  • 41. Histogenesis of benign pleomorphic adenoma (mixed tumor) of the major salivary glands. An ultrastructural and immunohistochemical study.
    Erlandson RA; Cardon-Cardo C; Higgins PJ
    Am J Surg Pathol; 1984 Nov; 8(11):803-20. PubMed ID: 6209992
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunohistochemical analysis of the p53 family members in human craniopharyngiomas.
    Momota H; Ichimiya S; Ikeda T; Yamaki T; Kikuchi T; Houkin K; Sato N
    Brain Tumor Pathol; 2003; 20(2):73-7. PubMed ID: 14756444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. p73 expression modulates p63 and Mdm2 protein presence in complex with p53 family-specific DNA target sequence in squamous cell carcinogenesis.
    Johnson J; Lagowski J; Lawson S; Liu Y; Kulesz-Martin M
    Oncogene; 2008 Apr; 27(19):2780-7. PubMed ID: 18026135
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.
    Gaiddon C; Lokshin M; Ahn J; Zhang T; Prives C
    Mol Cell Biol; 2001 Mar; 21(5):1874-87. PubMed ID: 11238924
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monoclonal antibodies raised against Xenopus p53 interact with human p73.
    Le Bras M; Delattre V; Bensaad K; Blandino G; Soussi T
    Oncogene; 2002 Feb; 21(8):1304-8. PubMed ID: 11850851
    [TBL] [Abstract][Full Text] [Related]  

  • 46. p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor.
    Jung MS; Yun J; Chae HD; Kim JM; Kim SC; Choi TS; Shin DY
    Oncogene; 2001 Sep; 20(41):5818-25. PubMed ID: 11593387
    [TBL] [Abstract][Full Text] [Related]  

  • 47. p63 expression in benign and malignant breast lesions.
    Stefanou D; Batistatou A; Nonni A; Arkoumani E; Agnantis NJ
    Histol Histopathol; 2004 Apr; 19(2):465-71. PubMed ID: 15024707
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The p53 family member genes are involved in the Notch signal pathway.
    Sasaki Y; Ishida S; Morimoto I; Yamashita T; Kojima T; Kihara C; Tanaka T; Imai K; Nakamura Y; Tokino T
    J Biol Chem; 2002 Jan; 277(1):719-24. PubMed ID: 11641404
    [TBL] [Abstract][Full Text] [Related]  

  • 49. p63 and p73 are not required for the development and p53-dependent apoptosis of T cells.
    Senoo M; Manis JP; Alt FW; McKeon F
    Cancer Cell; 2004 Jul; 6(1):85-9. PubMed ID: 15261144
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions.
    Nylander K; Coates PJ; Hall PA
    Int J Cancer; 2000 Aug; 87(3):368-72. PubMed ID: 10897041
    [TBL] [Abstract][Full Text] [Related]  

  • 51. From p63 to p53 across p73.
    Strano S; Rossi M; Fontemaggi G; Munarriz E; Soddu S; Sacchi A; Blandino G
    FEBS Lett; 2001 Feb; 490(3):163-70. PubMed ID: 11223031
    [TBL] [Abstract][Full Text] [Related]  

  • 52. p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes.
    Dohn M; Zhang S; Chen X
    Oncogene; 2001 May; 20(25):3193-205. PubMed ID: 11423969
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The p53 gene family.
    Kaelin WG
    Oncogene; 1999 Dec; 18(53):7701-5. PubMed ID: 10618710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transcriptional dysregulation of the p73L / p63 / p51 / p40 / KET gene in human squamous cell carcinomas: expression of Delta Np73L, a novel dominant-negative isoform, and loss of expression of the potential tumour suppressor p51.
    Senoo M; Tsuchiya I; Matsumura Y; Mori T; Saito Y; Kato H; Okamoto T; Habu S
    Br J Cancer; 2001 May; 84(9):1235-41. PubMed ID: 11336476
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The relationship between p63 and p53 expression in normal and neoplastic breast tissue.
    Ribeiro-Silva A; Zambelli Ramalho LN; Britto Garcia S; Zucoloto S
    Arch Pathol Lab Med; 2003 Mar; 127(3):336-40. PubMed ID: 12653579
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure, function and regulation of p63 and p73.
    Levrero M; De Laurenzi V; Costanzo A; Gong J; Melino G; Wang JY
    Cell Death Differ; 1999 Dec; 6(12):1146-53. PubMed ID: 10637429
    [TBL] [Abstract][Full Text] [Related]  

  • 57. p63 expression profiles in human normal and tumor tissues.
    Di Como CJ; Urist MJ; Babayan I; Drobnjak M; Hedvat CV; Teruya-Feldstein J; Pohar K; Hoos A; Cordon-Cardo C
    Clin Cancer Res; 2002 Feb; 8(2):494-501. PubMed ID: 11839669
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutation of the p51/p63 gene is associated with blastic crisis in chronic myelogenous leukemia.
    Yamaguchi H; Inokuchi K; Sakuma Y; Dan K
    Leukemia; 2001 Nov; 15(11):1729-34. PubMed ID: 11681414
    [TBL] [Abstract][Full Text] [Related]  

  • 59. p63 and p73 in human cancer: defining the network.
    Deyoung MP; Ellisen LW
    Oncogene; 2007 Aug; 26(36):5169-83. PubMed ID: 17334395
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dysregulated ΔNp63α negatively regulates the maspin promoter in keratinocytes via blocking endogenous p73 binding.
    King KE; Reddi DM; Ponnamperuma RM; Gerdes M; Weinberg WC
    Mol Carcinog; 2014 Sep; 53(9):698-710. PubMed ID: 23475637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.